Related Experiment Videos

Invasive phenotype of primary human prostatic epithelial cells

L J Scott¹, N W Clarke, M S Sharrard

¹Department of Urology and Paterson Institute CRC Research Laboratories, Christie Hospital, Manchester, UK.

Prostate Cancer and Prostatic Diseases

|December 24, 2002

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Predictors of traumatic brain injury amongst secondary school students in England: A retrospective cohort study using electronic health records.

Injury·2026

Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).

Annals of oncology : official journal of the European Society for Medical Oncology·2024

A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023

MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer.

Oncogene·2022

See all related articles